Evolution of the Market Access Environment for Pharma and Outlook for 2024

Alex joined GlobalData in 2022 as a Principal Research Analyst providing pricing and reimbursement, and market access analysis developments as part of the PharmOnline International (POLI) database. Prior to joining GlobalData, she worked at Beacon Intelligence, first as a lead gene therapy analyst and manager, then as a senior manager of research operations. Alex graduated from University College London (UCL) with a MSc in Pharmaceutical Formulation and Entrepreneurship in 2019, after completing a BSc (Hons) in Molecular Biology from the University of St. Andrews.

Milena Izmirlieva heads GlobalData’s Health Economics and Market Access research and analysis team, which comprises senior analysts, analysts, and health economists covering developed and emerging markets worldwide. Since joining one of GlobalData’s predecessor companies in 2003 as a pharma research analyst for Western European and Central and Eastern European markets, she has developed extensive knowledge of the healthcare systems and pharmaceutical markets of numerous countries in Europe, North America, and various emerging markets.
Prior to that, Milena worked in healthcare marketing communications for the EURO RSCG group in New York, US, and Sofia, Bulgaria, where she specialized in pharmaceutical and medical device companies. Her main areas of research interest are pricing and reimbursement and market access for originator drugs; the market dynamics for biosimilars and generics; health system efficiency indicators and health system capacity; and forecasting healthcare spending and pharmaceutical sales.
She holds an MSc degree in Health Economics, Policy, and Management from the London School of Economics and Political Science (LSE), an MSc degree in Communication with a focus on Science Writing from Iowa State University, and a joint BA degree in Journalism, Mass Communication, and International Relations from the American University in Bulgaria. Milena is a regular speaker at pharmaceutical conferences and is often interviewed about pharmaceutical-related issues in the media.
She frequently presents peer-reviewed research at ISPOR and has a strong interest in pharmaceutical pricing and reimbursement developments and cost-containment strategies (including international reference pricing).

Cyrus Fan is a Research Analyst in the GlobalData Life Sciences team focusing on the US and Canadian markets. Cyrus is responsible for daily analysis on these markets, providing updates on pricing and reimbursement, market access, regulatory and policy developments which affect the pharmaceutical industry. In addition, he is responsible for providing deeper analysis in special reports on specific topics and for producing GlobalData’s Market Access Month Ahead report. Before joining GlobalData, Cyrus completed his PhD in Diabetes, Endocrinology and Metabolism in January 2022 and holds an MSci in Pharmacology, both degrees completed at King’s College London. He is fluent in English and speaks conversational Chinese Cantonese.

Chia Lin provides coverage and analysis of healthcare and market access developments in the Asia-Pacific region.
Chia joined GlobalData in 2022 as a research analyst and is responsible for providing analysis of healthcare policy, pricing and reimbursement, and market access developments in Asia-Pacific markets.
She holds a master’s degree in international relations from King’s College London and a bachelor’s degree in humanities and social sciences from the National Tsing Hua University. Prior to joining GlobalData, Chia worked for McAndrew Leadership, an NPO consulting company. She is fluent in English and Mandarin.Chia Lin provides coverage and analysis of healthcare and market access developments in the Asia-Pacific region.
Chia joined GlobalData in 2022 as a research analyst and is responsible for providing analysis of healthcare policy, pricing and reimbursement, and market access developments in Asia-Pacific markets.
She holds a master’s degree in international relations from King’s College London and a bachelor’s degree in humanities and social sciences from the National Tsing Hua University. Prior to joining GlobalData, Chia worked for McAndrew Leadership, an NPO consulting company. She is fluent in English and Mandarin.

Brendan Melck is a Senior Research Analyst, specializing in Germany, Central and Eastern Europe, the Balkans and Greece. He is responsible for daily updates on regulatory and business developments affecting the pharmaceutical industry, as well as in-depth reports on specific topics and markets. In the 10+ years of covering the same regions for GlobalData and its predecessor companies, he has acquired a long-term view of the specific regulatory issues affecting these markets. Previously, Brendan worked for six years as an analyst for Esmerk (now mBrain, formerly part of the Finnish Sanoma media group), covering the Polish market. Prior to that, he worked in the education sector, as a teacher of English as a foreign language. He has a BA in English and History from the University of London and is fluent in German and Polish.

Janet is a Senior Research Analyst on GlobalData's health economics and market access team, which she joined (in a predecessor company) eight years ago. She covers European and Eurasian markets, with her main focuses on the UK, Switzerland, Romania, and Russia and other CIS countries. She has extensive experience in coverage of the pharma sector, particularly biotech R&D, gained over several years at Informa Citeline, Thomson Derwent, and the British Library. She has an MSc in Biochemistry and Applied Molecular Biology from UMIST (Manchester), and a BSc in Microbiology from Aberdeen University.